Triple Hair Inc. Alopecia Treatment Biotech Investor Presentation

Triple Hair Inc. is a Canadian biotechnology company developing innovative therapies for alopecia using a patented combination of existing molecules (TH07). The company has 20 patents covering major global markets and has received Canadian approval to initiate Phase III trials, with submissions pending in the USA, Europe, and India for a market valued at US$8.2 billion.